During the past decade, Hokkaido University Graduate School of Medicine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hokkaido University Graduate School of Medicine" #1 sponsor was "Hokkaido Gastrointestinal Cancer Study Group" with 8 trials, followed by "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "AO Clinical Investigation and Publishing Documentation" with 1 trials sponsored and "Hokkaido Pancreatobiliary Endoscopic Intervention Study Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hokkaido University Graduate School of Medicine" #1 collaborator was "Hokkaido University Hospital" with 8 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Japan Clinical Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hokkaido University Graduate School of Medicine" are "Colorectal Cancer" (4 trials), "Esophageal Cancer" (2 trials), "Gastric Cancer" (2 trials), "Sarcoma" (2 trials) and "Bone Infection" (1 trials). Many other conditions were trialed in "Hokkaido University Graduate School of Medicine" in a lesser frequency.

Most popular intervention types in "Hokkaido University Graduate School of Medicine" are "Drug" (14 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Taxotere" (3 trials), "5-FU" (2 trials), "5-Fluorouracil" (2 trials), "Briplatin" (2 trials) and "TS-1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hokkaido University Graduate School of Medicine" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Hokkaido University Graduate School of Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hokkaido University Graduate School of Medicine, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hokkaido University Graduate School of Medicine, 5 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".